These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 634333)
1. Profitable and nonprofitable drugs. Van Woert MH N Engl J Med; 1978 Apr; 298(16):903-6. PubMed ID: 634333 [No Abstract] [Full Text] [Related]
2. NIH urged to cap profits made on publicly funded research. Macilwain C Nature; 2000 Jul; 406(6791):5. PubMed ID: 10894508 [No Abstract] [Full Text] [Related]
3. Orphan products development and some methods for maximizing the usefulness of research on rare diseases. Finkel MJ Prog Clin Biol Res; 1985; 197():11-8. PubMed ID: 4070285 [No Abstract] [Full Text] [Related]
4. Role of the federal Government in health and medical affairs. Lee PR N Engl J Med; 1968 Nov; 279(21):1139-47. PubMed ID: 5686482 [No Abstract] [Full Text] [Related]
9. The Orphan Products Board of the Department of Health & Human Services. Crooks GM Prog Clin Biol Res; 1985; 197():19-23. PubMed ID: 4070294 [No Abstract] [Full Text] [Related]
11. One year in--Obama's biotech scorecard. Fox JL Nat Biotechnol; 2010 Mar; 28(3):193-6. PubMed ID: 20212475 [No Abstract] [Full Text] [Related]
12. [Orphan drugs]. Galeffi C Ann Ist Super Sanita; 1991; 27(2):341-3. PubMed ID: 1661568 [TBL] [Abstract][Full Text] [Related]
13. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry. Dorfman HL; Reig LP Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876 [No Abstract] [Full Text] [Related]
14. Research regulation, and development of new pharmaceuticals: past, present, and future. 1. Lasagna L Am J Med Sci; 1972 Jan; 263(1):9-18. PubMed ID: 4257990 [No Abstract] [Full Text] [Related]
15. FDA issues concerning conflicts of interest. Kurt TL IRB; 1990; 12(5):6-9. PubMed ID: 11654003 [No Abstract] [Full Text] [Related]
16. Therapeutic equivalency of drugs. Fact or fiction? Stetler CJ Med Ann Dist Columbia; 1969 Jun; 38(6):297-300. PubMed ID: 5257886 [No Abstract] [Full Text] [Related]
17. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products. Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700 [No Abstract] [Full Text] [Related]
18. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories. Jimenez FA Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711 [No Abstract] [Full Text] [Related]